FDA Evaluating Outsourcing Of Remarketer Regulation For 1999 Proposed Rule
This article was originally published in The Gray Sheet
Executive Summary
FDA is contemplating outsourcing regulation of device remarketers through the use of recognized standards and third-party inspectors, agency staffers say.